Perrigo to Buy Elan for $8.6B to Get Irish Tax Base

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 29 (Bloomberg) -- Perrigo, a U.S. maker of over-the-counter medicines, agreed to buy Irish drug company Elan for $8.6 billion, gaining a low-tax base for international expansion. Olivia Sterns reports on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change